140 related articles for article (PubMed ID: 2687804)
1. Hepatic veno-occlusive disease following bone marrow transplantation.
Grandt NC
Oncol Nurs Forum; 1989; 16(6):813-7. PubMed ID: 2687804
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation.
Rosenthal J; Sender L; Secola R; Killen R; Millerick M; Murphy L; Cairo MS
Bone Marrow Transplant; 1996 Jul; 18(1):185-91. PubMed ID: 8832013
[TBL] [Abstract][Full Text] [Related]
3. Veno-occlusive disease of the liver complicating bone marrow transplantation.
Baglin TP
Bone Marrow Transplant; 1994 Jan; 13(1):1-4. PubMed ID: 8019444
[TBL] [Abstract][Full Text] [Related]
4. Veno-occlusive disease is the most common hepatic complication in stem cell transplants.
Becze E
ONS Connect; 2012 Nov; 27(11):16-7. PubMed ID: 23316521
[No Abstract] [Full Text] [Related]
5. [Veno-occlusive disease after bone marrow transplantation: preventive effect of heparin].
Parquet N; Devergie A; Socié G; Ribaud P; Espérou H; Gluckman E
Ann Med Interne (Paris); 1997; 148(2):132-5. PubMed ID: 9238437
[TBL] [Abstract][Full Text] [Related]
6. [Percutaneous intrahepatic portosystemic shunting in the treatment of veno-occlusive disease of the liver after bone marrow transplantation].
Alvarez R; Bañares R; Casariego J; Echenagusía A; Simó G; Alvarez E; Serrano D; Díez-Martín JL
Gastroenterol Hepatol; 2000 Apr; 23(4):177-80. PubMed ID: 10863859
[TBL] [Abstract][Full Text] [Related]
7. A review of tissue plasminogen activator in the treatment of veno-occlusive liver disease after bone marrow transplantation.
Terra SG; Spitzer TR; Tsunoda SM
Pharmacotherapy; 1997; 17(5):929-37. PubMed ID: 9324182
[TBL] [Abstract][Full Text] [Related]
8. Parameters of the fibrinolytic system in patients undergoing BMT: elevation of PAI-1 in veno-occlusive disease.
Salat C; Holler E; Reinhardt B; Kolb HJ; Seeber B; Ledderose G; Mittermueller J; Duell T; Wilmanns W; Hiller E
Bone Marrow Transplant; 1994 Nov; 14(5):747-50. PubMed ID: 7889007
[TBL] [Abstract][Full Text] [Related]
9. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors.
Hasegawa S; Horibe K; Kawabe T; Kato K; Kojima S; Matsuyama T; Hirabayashi N
Bone Marrow Transplant; 1998 Dec; 22(12):1191-7. PubMed ID: 9894723
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia.
Rozman C; Carreras E; Qian C; Gale RP; Bortin MM; Rowlings PA; Ash RC; Champlin RE; Henslee-Downey PJ; Herzig RH; Hinterberger W; Klein JP; Prentice HG; Reiffers J; Zwaan FE; Horowitz MM
Bone Marrow Transplant; 1996 Jan; 17(1):75-80. PubMed ID: 8673059
[TBL] [Abstract][Full Text] [Related]
11. The veno-occlusive disease of the liver.
Baron F; Deprez M; Beguin Y
Haematologica; 1997; 82(6):718-25. PubMed ID: 9499675
[TBL] [Abstract][Full Text] [Related]
12. Hepatic veno-occlusive disease following peripheral blood stem cell or bone marrow transplantation.
Salat C; Holler E; Hiller E; Pihusch R; Kolb HJ
Haematologica; 1999 Jun; 84 Suppl EHA-4():40-3. PubMed ID: 10907464
[No Abstract] [Full Text] [Related]
13. Allogeneic liver transplantation for hepatic veno-occlusive disease after bone marrow transplantation--clinical and immunological considerations.
Schlitt HJ; Tischler HJ; Ringe B; Raddatz G; Maschek H; Dietrich H; Kuse E; Pichlmayr R; Link H
Bone Marrow Transplant; 1995 Sep; 16(3):473-8. PubMed ID: 8535323
[TBL] [Abstract][Full Text] [Related]
14. [Acute renal failure secondary to hepatic veno-occlusive disease in a bone marrow transplant patient].
Borrego FJ; Viedma G; Pérez del Barrio P; Gil JM; de Santis-Scoccia C; Ramírez Huerta JM; Alcalá A; Pérez Bañasco V
Nefrologia; 2003; 23(4):350-4. PubMed ID: 14558335
[TBL] [Abstract][Full Text] [Related]
15. Changes in protein C, factor VII and endothelial markers after autologous bone marrow transplantation: possible implications in the pathogenesis of veno-occlusive disease.
Bazarbachi A; Scrobohaci ML; Gisselbrecht C; Marolleau JP; Mansi A; Brice P; Gorra P; Drouet L
Nouv Rev Fr Hematol (1978); 1993 Apr; 35(2):135-40. PubMed ID: 8332449
[TBL] [Abstract][Full Text] [Related]
16. Recombinant tissue plasminogen activator for treatment of hepatic veno-occlusive disease following bone marrow transplantation in children: effectiveness and a scoring system for initiating treatment.
Bajwa RP; Cant AJ; Abinun M; Flood TJ; Hodges S; Hale JP; Skinner R
Bone Marrow Transplant; 2003 Apr; 31(7):591-7. PubMed ID: 12692627
[TBL] [Abstract][Full Text] [Related]
17. Management of hepatic veno-occlusive disease (VOD) in pediatric patients: retrospective analysis in 6 AIEOP-BMT (Italian Pediatric Hematology Oncology Association-Bone Marrow Transplantation Group) Centers.
Miniero R; Vassallo E; Soldano S; Nesi F; Vai S; Balduzzi A; Varotto S; Dallorso S; Prete A; Arcese W
Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():157-9. PubMed ID: 8932820
[No Abstract] [Full Text] [Related]
18. Post-bone marrow transplant patient management.
Poliquin CM
Yale J Biol Med; 1990; 63(5):495-502. PubMed ID: 2293508
[TBL] [Abstract][Full Text] [Related]
19. Liver dysfunction in the early post-bone marrow transplant period.
Storek J
Cas Lek Cesk; 1996 May; 135(10):295-8. PubMed ID: 8697490
[TBL] [Abstract][Full Text] [Related]
20. Hepatic veno-occlusive disease following bone marrow transplantation treated by prostaglandin E1.
Ibrahim A; Pico JL; Maraninchi D; Zambon E; Attal M; Brault P; Tilly H; Blaise D; Hayat M
Bone Marrow Transplant; 1991; 7 Suppl 2():53. PubMed ID: 1878718
[No Abstract] [Full Text] [Related]
[Next] [New Search]
